XNAS
JSPR
Market cap45mUSD
Jul 08, Last price
3.02USD
1D
-0.66%
1Q
-16.57%
IPO
-69.25%
Name
Jasper Therapeutics Inc
Chart & Performance
P/E
—
P/S
—
EPS
—
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
0k
Net income
0k
P
CFO
-63m
L+20.23%
Earnings
Aug 11, 2025
Profile
Amplitude Healthcare Acquisition Corporation does not have significant operations. It intends to acquire assets and businesses through a merger, share exchange, share purchase, reorganization, or similar business combination with one or more businesses in the healthcare or healthcare related industries. The company was founded in 2019 and is based in New York, New York.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | ||||||
Cost of revenue | 76,239 | 69,969 | 52,506 | |||
Unusual Expense (Income) | ||||||
NOPBT | (76,239) | (69,969) | (52,506) | |||
NOPBT Margin | ||||||
Operating Taxes | (1,628) | (13,511) | ||||
Tax Rate | ||||||
NOPAT | (76,239) | (68,341) | (38,995) | |||
Net income | (64,465) 166.67% | (24,174) 0.79% | ||||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 47,195 | 101,479 | 83 | |||
BB yield | -15.14% | -1,232.08% | -4.71% | |||
| Debt | ||||||
Debt current | 1,089 | 1,944 | 865 | |||
Long-term debt | 2,537 | 4,600 | 6,437 | |||
Deferred revenue | (563) | |||||
Other long-term liabilities | 2,264 | 2,264 | 2,521 | |||
Net debt | (68,011) | (80,343) | (31,365) | |||
| Cash flow | ||||||
Cash from operating activities | (62,602) | (52,067) | (45,858) | |||
CAPEX | (552) | (267) | (576) | |||
Cash from investing activities | (532) | (267) | (576) | |||
Cash from financing activities | 47,884 | 100,971 | 55 | |||
FCF | (74,896) | (67,081) | (39,616) | |||
| Balance | ||||||
Cash | 71,637 | 86,887 | 38,250 | |||
Long term investments | 417 | |||||
Excess cash | 71,637 | 86,887 | 38,667 | |||
Stockholders' equity | (240,867) | (169,599) | (56,770) | |||
Invested Capital | 306,618 | 254,061 | 98,368 | |||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 14,585 | 10,439 | 3,648 | |||
Price | 21.38 2,609.76% | 0.79 63.39% | 0.48 -93.85% | |||
Market cap | 311,825 3,685.93% | 8,236 367.51% | 1,762 -80.30% | |||
EV | 243,814 | (72,107) | 18,758 | |||
EBITDA | (74,866) | (68,861) | (51,531) | |||
EV/EBITDA | 1.05 | |||||
Interest | 13,511 | |||||
Interest/NOPBT | ||||||